Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,305 public trials 1,294 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

NCT04961619

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Novartis Investigative Site Antalya, Konyaalti, Turkey (Türkiye)
  • Novartis Investigative Site Edirne, Merkez, Turkey (Türkiye)
  • Novartis Investigative Site Bursa, Nilufer, Turkey (Türkiye)
  • Novartis Investigative Site Diyarbakır, Sur, Turkey (Türkiye)
View Trial Details
Completed

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01950390

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 482 locations
View Trial Details
Completed

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

NCT05432375

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Hospital Universitario Vall d'Hebron, Barcelona, Spain Barcelona, Spain
  • Hospital Universitario Ramón y Cajal, Madrid, Spain Madrid, Spain
  • South Texas Accelerated Research Therapeutics (START) Madrid, Spain
  • Kantonsspital Sankt Gallen, Switzerland
View Trial Details
Completed

First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma

NCT04116658

Conditions
Astrocytoma, Glioblastoma, Glioblastoma, Adult, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Centre Georges François Leclerc Dijon, France
  • Hôpital Pitié-Salpétrière Paris, France
  • Klinik und Poliklinik für Neurologie Universitätsklinikum Bonn Bonn, Germany
View Trial Details
Completed

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

NCT03224104

Conditions
Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +8 more
Locations
  • Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken Vienna, Austria
  • CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer Bron, France
  • CHRU de Lille Lille, France
  • Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone Marseille, France
View Trial Details

Related conditions